GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Novation Companies Inc (OTCPK:NOVCQ) » Definitions » ROE %

Novation (Novation) ROE % : 0.00% (As of Sep. 2021)


View and export this data going back to 1997. Start your Free Trial

What is Novation ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Novation's annualized net income for the quarter that ended in Sep. 2021 was $-5.51 Mil. Novation's average Total Stockholders Equity over the quarter that ended in Sep. 2021 was $-84.35 Mil. Therefore, Novation's annualized ROE % for the quarter that ended in Sep. 2021 was N/A%.

The historical rank and industry rank for Novation's ROE % or its related term are showing as below:

NOVCQ's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.035
* Ranked among companies with meaningful ROE % only.

Novation ROE % Historical Data

The historical data trend for Novation's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novation ROE % Chart

Novation Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Equity - Negative Equity - -

Novation Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Novation's ROE %

For the Medical Care Facilities subindustry, Novation's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novation's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novation's ROE % distribution charts can be found below:

* The bar in red indicates where Novation's ROE % falls into.



Novation ROE % Calculation

Novation's annualized ROE % for the fiscal year that ended in Dec. 2020 is calculated as

ROE %=Net Income (A: Dec. 2020 )/( (Total Stockholders Equity (A: Dec. 2019 )+Total Stockholders Equity (A: Dec. 2020 ))/ count )
=-9.169/( (-72.059+-81.09)/ 2 )
=-9.169/-76.5745
=N/A %

Novation's annualized ROE % for the quarter that ended in Sep. 2021 is calculated as

ROE %=Net Income (Q: Sep. 2021 )/( (Total Stockholders Equity (Q: Jun. 2021 )+Total Stockholders Equity (Q: Sep. 2021 ))/ count )
=-5.512/( (-83.679+-85.026)/ 2 )
=-5.512/-84.3525
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2021) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Novation  (OTCPK:NOVCQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2021 )
=Net Income/Total Stockholders Equity
=-5.512/-84.3525
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.512 / 39.772)*(39.772 / 10.351)*(10.351 / -84.3525)
=Net Margin %*Asset Turnover*Equity Multiplier
=-13.86 %*3.8423*N/A
=ROA %*Equity Multiplier
=-53.25 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2021 )
=Net Income/Total Stockholders Equity
=-5.512/-84.3525
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5.512 / -5.512) * (-5.512 / -2.04) * (-2.04 / 39.772) * (39.772 / 10.351) * (10.351 / -84.3525)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 2.702 * -5.13 % * 3.8423 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Sep. 2021) net income data. The Revenue data used here is four times the quarterly (Sep. 2021) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Novation ROE % Related Terms

Thank you for viewing the detailed overview of Novation's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novation (Novation) Business Description

Traded in Other Exchanges
N/A
Address
9229 Ward Parkway, Suite 340, Kansas City, MO, USA, 64114
Novation Companies Inc provides outsourced health care staffing and related services in the State of Georgia. Services are performed by medical staff on-site at the company's clients' facilities.
Executives
Lee D Keddie director 1110 W. LAKE COOK ROAD SUITE 220 BUFFALO GROVE IL 60089
David William Pointer director, officer: Chief Executive Officer PO BOX 402, NEWMAN LAKE WA 99025
Howard Amster director 23811 CHAGRIN BLVD # 200, BEACHWOOD OH 44122-5525
Barry Igdaloff director
Howard Timothy Eriksen director 567 WILDROSE CIRCLE, LYNDEN WA 98264
Jeffrey E. Eberwein director, officer: Executive Chairman 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Charles M Gillman director 1223 WILSHIRE BOULEVARD, OFFICE 648, SANTA MONICA CA 90402
Robert G. Pearse director 100 CANAL POINTE BLVD., SUITE 108, PRINCETON NJ 08540
Carolyn K. Campbell officer: Chief Financial Officer C/O NOVATION COMPANIES, INC. 500 GRAND BOULEVARD, SUITE 201B KANSAS CITY MO 64106
Richard Rector other: See Remarks C/O NOVATION COMPANIES, INC. 500 GRAND BOULEVARD, SUITE 201B KANSAS CITY MO 64106
W Lance Anderson officer: President and COO 2114 CENTRAL ST STE 600 KANSAS CITY MO 64108
Gregory T Barmore director C/O NOVASTAR FINANCIAL INC, 8140 WARD PARKWAY, STE 300, KANSAS CITY MO 64114
Steve M Haslam officer: Chief Operating Officer 2114 CENTRAL STREET SUITE 600 KANSAS CITY MO 64108
Edward W Mehrer director C/O NOVASTAR FINANCIAL INC 8140 WARD PARKWAY, STE 300 KANSAS CITY MO 64114
Art N Burtscher director C/O NOVASTAR FINANCIAL INC 8140 WARD PARKWAY, STE 300 KANSAS CITY MO 64114

Novation (Novation) Headlines

From GuruFocus